Provided by Tiger Trade Technology Pte. Ltd.

ESG Concept

1,470.507
-20.939-1.40%
Number of Gainers:5
Number of Losers:5
Number of Flat:- -
PE:- -
High:1,473.845
Open:1,466.395
Low:1,466.029
Close:1,491.446
Volume:6.96M
Turnover:307.27M
Market Cap:1.29T
Float Cap:1.25T

Loading ...

Woolworths Group (ASX:WOW) Lifted Profit And Dividends, Is The Stock Fully Valued?

Simply Wall St.
·
Sep 01

ASX Midday Sector Update: Energy Stocks Advance, Consumer Discretionary Sector Struggles

MT Newswires Live
·
Sep 01

CSL's U.S. Agreements Remove Two Stock Overhangs

Dow Jones
·
Sep 01

ASX Preview: Australian Shares to Fall as Oil Surges on US-Iran Conflict; Ausgold Fiscal 2026 Loss Narrows

MT Newswires Live
·
Sep 01

ANZ Report Flags Australians Shift to Cheaper Grocery Options as Food Prices Stay Elevated

Reuters
·
Sep 01

CSL Secures US Agreements to Cut Medicine Costs, Expand Manufacturing

MT Newswires Live
·
Sep 01

Market Chatter: ANZ Group Said to Mull Judo Acquisition, The Australian Says

MT Newswires Live
·
Sep 01

CSL Signs U.S. Government Agreements to Lower Drug Prices for Medicaid

Reuters
·
Sep 01

CSL Limited-Agreements with U.S. on Drug Prices and Manufacturing

THOMSON REUTERS
·
Sep 01

Trump Administration Announces Drug Pricing Deals with CSL, Astellas and Others

Reuters
·
Sep 01

CSL Ltd: Agreements Support Lower Prices for CSL Therapies and Reflect CSL's $1.5 Billion Plan to Expand Its U.S. Manufacturing Capacity in Illinois

THOMSON REUTERS
·
Sep 01

CSL Enters Agreements with the U.S. Government to Lower Drug Prices and Support Investment in U.S. Manufacturing

THOMSON REUTERS
·
Sep 01

CSL : Agreements Provide CSL with Additional Certainty Regarding Exposure to U.S. Drug Pricing & Certain Section 232 Tariffs

THOMSON REUTERS
·
Sep 01

CSL : Entered into Onshoring Agreement with the U.S. Department of Commerce

THOMSON REUTERS
·
Sep 01

CSL : Project to Substantially Increase Co's Ability to Produce Immunoglobulins & Albumin for People with Rare Diseases & Serious Conditions

THOMSON REUTERS
·
Sep 01

CSL Ltd: Project is Expected to Create at Least 300 New Pharmaceutical Manufacturing Jobs and Approximately 800 Construction and Related Jobs

THOMSON REUTERS
·
Sep 01

CSL : Does not Anticipate Any Material Impact During Fiscal Year 2027

THOMSON REUTERS
·
Sep 01

Overvalued ASX giant faces retail challenges

Morning Star AU
·
Sep 01

Founder Led Stocks With Long Term Alignment Investors Should Watch

Simply Wall St.
·
Aug 31

Australian Shares End Lower as Miners Drag

Reuters
·
Aug 31